Journal article · 2026
Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity
Journal of Medicinal Chemistry, 69(21), 25434–25447 · Published 31 October 2026 · DOI 10.1021/acs.jmedchem.6c01364
In brief
“Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity” is a 2026 journal article by Yingying Zuo and 10 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 0 citations as of 17 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 39
- Authors
- 11
Abstract
TGFβ-activated kinase 1 (TAK1) plays essential roles in proinflammatory and prosurvival signaling pathways, and has been implicated in various human diseases, including cancer and inflammation. Although several TAK1 inhibitors have been reported, an effective tool compound with a combination of favorable potency, selectivity, and in vivo efficacy is still lacking. Herein, we present a 7-aminofuro[2,3-c]pyridine-based… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zuo, Y., Fu, T., Chen, X., He, F., Chen, X., Wortmann, L., Schulze, V., Heinrich, T. K., Suelzle, D., von Nussbaum, F., & Pan, Z. (2026). Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity. Journal of Medicinal Chemistry, 69(21), 25434–25447. https://doi.org/10.1021/acs.jmedchem.6c01364
MLA 9
Zuo, Yingying, et al. “Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity.” Journal of Medicinal Chemistry, vol. 69, no. 21, 2026, pp. 25434–25447. https://doi.org/10.1021/acs.jmedchem.6c01364.
Chicago
Zuo, Yingying, Tiancheng Fu, Xuan Chen, Fengli He, Xingwei Chen, Lars Wortmann, Volker Schulze, et al. 2026. “Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity.” Journal of Medicinal Chemistry 69 (21): 25434–25447. https://doi.org/10.1021/acs.jmedchem.6c01364.
Harvard
Zuo, Y. et al. (2026) ‘Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity’, Journal of Medicinal Chemistry, 69(21), pp. 25434–25447. doi:10.1021/acs.jmedchem.6c01364.
IEEE
Y. Zuo et al., “Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity,” Journal of Medicinal Chemistry, vol. 69, no. 21, pp. 25434–25447, 2026, doi: 10.1021/acs.jmedchem.6c01364.
BibTeX
@article{zuo2026discovery,
title = {{Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity}},
author = {Zuo, Yingying and Fu, Tiancheng and Chen, Xuan and He, Fengli and Chen, Xingwei and Wortmann, Lars and Schulze, Volker and Heinrich, Tobias Kerst and Suelzle, Detlev and von Nussbaum, Franz and Pan, Zhengying},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {21},
pages = {25434--25447},
doi = {10.1021/acs.jmedchem.6c01364},
url = {https://doi.org/10.1021/acs.jmedchem.6c01364}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- TAK1
- α,β-unsaturated aldehydes
- anticancer activity
- lymphoma
- kinase selectivity
Work with this paper
Most-cited papers in Chemistry
- CRC Handbook of Chemistry and PhysicsW.M. Haynes · CRC Press eBooks · 2014 · 58,210 citations
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Harry Towbin, Th. Staehelin, J Gordon · Proceedings of the National Academy of Sciences · 1979 · 53,242 citations
- Crystal structure refinement with SHELXLGeorge M. Sheldrick · Acta Crystallographica Section C Structural Chemistry · 2014 · 45,305 citations
- Comparison of simple potential functions for simulating liquid waterWilliam L. Jorgensen, Jayaraman Chandrasekhar, Jeffry D. Madura and 2 more · The Journal of Chemical Physics · 1983 · 41,735 citations
- Equation of State Calculations by Fast Computing MachinesN. Metropolis, Arianna W. Rosenbluth, M. N. Rosenbluth and 2 more · The Journal of Chemical Physics · 1953 · 38,111 citations
Questions about this paper
How do I cite this paper in APA style?
Zuo, Y., Fu, T., Chen, X., He, F., Chen, X., Wortmann, L., Schulze, V., Heinrich, T. K., Suelzle, D., von Nussbaum, F., & Pan, Z. (2026). Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity. Journal of Medicinal Chemistry, 69(21), 25434–25447. https://doi.org/10.1021/acs.jmedchem.6c01364
How many times has this paper been cited?
0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Yingying Zuo, Tiancheng Fu, Xuan Chen, Fengli He, Xingwei Chen, Lars Wortmann, Volker Schulze, Tobias Kerst Heinrich, Detlev Suelzle, Franz von Nussbaum, Zhengying Pan.
What is the DOI of this paper?
10.1021/acs.jmedchem.6c01364, permanently at https://doi.org/10.1021/acs.jmedchem.6c01364. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.